Testosterone therapy not linked to increased risk of cardiovascular events

Men given testosterone therapy to treat hypogonadism in the short-to-medium term are at no greater risk of cardiovascular events compared to men who are not receiving the treatment, new research suggests. Until now, the effects of testosterone treatment on heart health have been unclear. Previous studies have suggested that hormone replacement therapy could increase the risk of cardiovascular events, but these studies have relied on aggregate data rather than individual participant data. Lead author of the study, Jemma Hudson from the University of Aberdeen, says this new research provides “much-needed reassurance” to men undergoing testosterone therapy. “Our findings could have